Burgess A - Search Results

1

Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled.

Fung KY, Nice E, Priebe I, Belobrajdic D, Phatak A, Purins L, Tabor B, Pompeia C, Lockett T, Adams TE, Burgess A, Cosgrove L. Fung KY, et al. Among authors: burgess a. World J Gastroenterol. 2014 Jan 28;20(4):888-98. doi: 10.3748/wjg.v20.i4.888. World J Gastroenterol. 2014. PMID: 24574763 Free PMC article. Review.

2

Performance of serum lipocalin 2 as a diagnostic marker for colorectal cancer.

Fung KY, Priebe I, Purins L, Tabor B, Brierley GV, Lockett T, Nice E, Gibbs P, Tie J, McMurrick P, Moore J, Ruszkiewicz A, Burgess A, Cosgrove LJ. Fung KY, et al. Among authors: burgess a. Cancer Biomark. 2013;13(2):75-9. doi: 10.3233/CBM-130335. Cancer Biomark. 2013. PMID: 23838135

3

Blood-based protein biomarker panel for the detection of colorectal cancer.

Fung KY, Tabor B, Buckley MJ, Priebe IK, Purins L, Pompeia C, Brierley GV, Lockett T, Gibbs P, Tie J, McMurrick P, Moore J, Ruszkiewicz A, Nice E, Adams TE, Burgess A, Cosgrove LJ. Fung KY, et al. Among authors: burgess a. PLoS One. 2015 Mar 20;10(3):e0120425. doi: 10.1371/journal.pone.0120425. eCollection 2015. PLoS One. 2015. PMID: 25793510 Free PMC article.

4

Serum concentrations of brain-derived neurotrophic factor (BDNF) are decreased in colorectal cancer patients.

Brierley GV, Priebe IK, Purins L, Fung KY, Tabor B, Lockett T, Nice E, Gibbs P, Tie J, McMurrick P, Moore J, Ruszkiewicz A, Burgess A, Cosgrove LJ. Brierley GV, et al. Among authors: burgess a. Cancer Biomark. 2013;13(2):67-73. doi: 10.3233/CBM-130345. Cancer Biomark. 2013. PMID: 23838134

5

Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces.

Ang CS, Rothacker J, Patsiouras H, Gibbs P, Burgess AW, Nice EC. Ang CS, et al. Electrophoresis. 2011 Aug;32(15):1926-38. doi: 10.1002/elps.201000502. Epub 2011 May 3. Electrophoresis. 2011. PMID: 21538981

6

Murine fecal proteomics: a model system for the detection of potential biomarkers for colorectal cancer.

Ang CS, Rothacker J, Patsiouras H, Burgess AW, Nice EC. Ang CS, et al. J Chromatogr A. 2010 May 7;1217(19):3330-40. doi: 10.1016/j.chroma.2009.10.007. Epub 2009 Oct 8. J Chromatogr A. 2010. PMID: 19875126

7

A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation.

Koziolek EJ, Donoghue JF, Bentley JD, Lovrecz G, Dolezal O, Ward CW, Rothacker J, Nice EC, Burgess AW, Hafner M, Johns TG, Adams TE. Koziolek EJ, et al. Growth Factors. 2012 Oct;30(5):310-9. doi: 10.3109/08977194.2012.709516. Epub 2012 Aug 2. Growth Factors. 2012. PMID: 22856597

8

Notch ligand delta-like1: X-ray crystal structure and binding affinity.

Kershaw NJ, Church NL, Griffin MD, Luo CS, Adams TE, Burgess AW. Kershaw NJ, et al. Biochem J. 2015 May 15;468(1):159-66. doi: 10.1042/BJ20150010. Biochem J. 2015. PMID: 25715738

9

A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo.

Adams TE, Koziolek EJ, Hoyne PH, Bentley JD, Lu L, Lovrecz G, Ward CW, Lee FT, Scott AM, Nash AD, Rothacker J, Nice EC, Burgess AW, Johns TG. Adams TE, et al. Growth Factors. 2009 Jun;27(3):141-54. doi: 10.1080/08977190902843565. Growth Factors. 2009. PMID: 19333814

10

Ligand binding induces a conformational change in epidermal growth factor receptor dimers.

Walker F, Rothacker J, Henderson C, Nice EC, Catimel B, Zhang HH, Scott AM, Bailey MF, Orchard SG, Adams TE, Liu Z, Garrett TP, Clayton AH, Burgess AW. Walker F, et al. Among authors: burgess aw. Growth Factors. 2012 Dec;30(6):394-409. doi: 10.3109/08977194.2012.739619. Epub 2012 Nov 20. Growth Factors. 2012. PMID: 23163584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,498 results

Search Page